Cardiol Therapeutics Inc. (TSX:CRDL)
1.500
+0.010 (0.67%)
Oct 8, 2025, 4:00 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 125.59 million as of October 8, 2025. Its market cap has decreased by -38.87% in one year.
Market Cap
125.59M
Enterprise Value
107.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 125.59M, an increase of 33.16%. That is a compound annual growth rate of 4.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 125.59M | -16.81% |
Dec 31, 2024 | 150.97M | 110.34% |
Dec 29, 2023 | 71.77M | 63.28% |
Dec 30, 2022 | 43.96M | -69.05% |
Dec 31, 2021 | 142.02M | 55.49% |
Dec 31, 2020 | 91.34M | -22.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 3.22B |
Green Thumb Industries | 2.76B |
Trulieve Cannabis | 2.26B |
dentalcorp Holdings | 2.17B |
Sienna Senior Living | 1.78B |
WELL Health Technologies | 1.39B |
Cronos Group | 1.39B |
Extendicare | 1.27B |